nach oben

Current Pulmonology Reports

Erschienen in:

03.05.2023 | INVITED COMMENTARY

Current Perspectives in Treatment of Obstructive Sleep Apnea: Positive Airway Pressure

verfasst von: Anirudh Nandan, Michael D. Faulx

Erschienen in: Current Pulmonology Reports | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Sleep apnea is prevalent and associated with increased overall and cardiovascular morbidity and mortality. Positive airway pressure has been the mainstay of treatment for decades, however newer treatments are available. We provide an update on the state of positive airway pressure delivery and its effectiveness compared to other sleep apnea treatments.

Recent Findings

Well-designed prospective cohort studies of sleep apnea have consistently demonstrated morbidity and mortality benefit with positive airway pressure. Randomized controlled trials have not consistently demonstrated such clear benefit, albeit with major limitations related to methodology and exclusion criteria. Positive airway pressure consistently outperforms weight loss, oral appliances, and hypoglossal nerve stimulation in sleep apnea treatment, however pre-treatment bias and discomfort remain barriers to compliance.

Summary

Although advances in medical, surgical and device- related management of sleep apnea show promise, positive airway pressure remains the most effective treatment. Advances in device and mask technology may improve compliance over time.

Lacasse Y, Godbout C, Sériès F. Health-related quality of life in obstructive sleep apnoea. Eur Respir J. 2002;19(3):499–503. https://doi.org/10.1183/09031936.02.00216902.CrossRefPubMed

Tietjens JR, Claman D, Kezirian EJ, De Marco T, Mirzayan A, Sadroonri B, Goldberg AN, Long C, Gerstenfeld EP, Yeghiazarians Y. Obstructive sleep apnea in cardiovascular disease: a review of the literature and proposed multidisciplinary clinical management strategy. J Am Heart Assoc. 2019;8:e010440. https://doi.org/10.1161/JAHA.118.010440.CrossRefPubMed

Goyal M, Johnson J. Obstructive sleep apnea diagnosis and management. Mo Med. 2017;114(2):120–4. PMID: 30228558; PMCID: PMC6140019.PubMedPubMedCentral

Sullivan CE, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet (London, England). 1981;1(8225):862–5. https://doi.org/10.1016/s0140-6736(81)92140-1.CrossRefPubMed

•• Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG. Treatment of adult obstructive sleep apnea with positive airway pressure: an american academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2019. https://doi.org/10.5664/jcsm.7640. This is an excellent contemporary review of the use of positive airway pressure (PAP) to treat obstructive sleep apnea. Authored by experts from the American Academy of Sleep Medicine, this practice guideline explains the data supporting the use of varied PAP modailities and makes practical treatment recommendations.CrossRefPubMedPubMedCentral

Chou MSH, Ting NCH, El-Turk N, Harrington Z, Dobler CC. Treatment burden experienced by patients with obstructive sleep apnoea using continuous positive airway pressure therapy. PLoS ONE. 2021;16(6):e0252915. https://doi.org/10.1371/journal.pone.0252915.CrossRefPubMedPubMedCentral

Cowie M, Woehrle H, et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med. 2015;373:1095–105. https://doi.org/10.1056/NEJMoa1506459.CrossRefPubMedPubMedCentral

Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG. Treatment of adult obstructive sleep apnea with positive airway pressure: An American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2019. https://doi.org/10.5664/jcsm.7638.CrossRefPubMedPubMedCentral

Ponce S, Pastor E, Orosa B, Oscullo G, Catalán P, Martinez A, Hernández L, Muriel A, Chiner E, Martínez-García MÁ. The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial. Eur Respir J. 2019;54(2):1900518. https://doi.org/10.1183/13993003.00518-2019.CrossRefPubMed

10.

McEvoy RD, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N England J Med. 2016;375(10):919–31. https://doi.org/10.1056/NEJMoa1606599.CrossRef

11.

Sánchez-de-la-Torre M, et al. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial. Lancet Respir Med. 2020;8(4):359–67. https://doi.org/10.1016/S2213-2600(19)30271-1.CrossRefPubMed

12.

Kushida CA, et al. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep. 2012;35(12):1593–602. https://doi.org/10.5665/sleep.2226.CrossRefPubMedPubMedCentral

13.

Barbé F, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;307(20):2161–8. https://doi.org/10.1001/jama.2012.4366.CrossRefPubMed

14.

Craig SE, et al. Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial. Thorax. 2012;67(12):1090–6. https://doi.org/10.1136/thoraxjnl-2012-202178.CrossRefPubMed

15.

McMillan A, et al. Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial. Lancet Respir Med. 2014;2(10):804–12. https://doi.org/10.1016/S2213-2600(14)70172-9.CrossRefPubMed

16.

Huang Z, et al. Long-term effects of continuous positive airway pressure on blood pressure and prognosis in hypertensive patients with coronary heart disease and obstructive sleep apnea: a randomized controlled trial. Am J Hypertens. 2015;28(3):300–6. https://doi.org/10.1093/ajh/hpu147.CrossRefPubMed

17.

Parra O, et al. Efficacy of continuous positive airway pressure treatment on 5-year survival in patients with ischaemic stroke and obstructive sleep apnea: a randomized controlled trial. J Sleep Res. 2015;24(1):47–53. https://doi.org/10.1111/jsr.12181.CrossRefPubMed

18.

Peker Y, et al. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea. The RICCADSA randomized controlled trial. Am J Respir Crit Care Med. 2016;194(5):613–20. https://doi.org/10.1164/rccm.201601-0088OC.CrossRefPubMed

19.

Shukla A, et al. Effect of obstructive sleep apnea treatment on atrial fibrillation recurrence: A meta-analysis. JACC Clin Electrophysiol. 2015;1(1–2):41–51. https://doi.org/10.1016/j.jacep.2015.02.014.CrossRefPubMed

20.

Holmqvist F, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015;169(5):647–654.e2. https://doi.org/10.1016/j.ahj.2014.12.024.CrossRefPubMed

21.

• Traaen GM, et al. Effect of continuous positive airway pressure on arrhythmia in atrial fibrillation and sleep apnea: A randomized controlled trial. Am J Respir Crit Care Med. 2021;204(5):573–82. https://doi.org/10.1164/rccm.202011-4133OC. This recent randomized controlled trial offers the reader a better understanding of how sleep apnea influences outcomes in patients with atrial fibrillation, and nicely illustrates the limitations of current randomized trials of positive airway pressure in heart disease that are highlighted in the body of the manuscript.CrossRefPubMed

22.

Hunt T-E, et al. Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trial. Heart Rhythm. 2022;19(9):1433–41. https://doi.org/10.1016/j.hrthm.2022.06.016.CrossRefPubMed

23.

Trzepizur W, Blanchard M, Ganem T, Balusson F, Feuilloy M, Girault JM, Meslier N, Oger E, Paris A, Pigeanne T, Racineux JL, Sabil A, Gervès-Pinquié C, Gagnadoux F. Sleep apnea-specific hypoxic burden, symptom subtypes, and risk of cardiovascular events and all-cause mortality. Am J Respir Crit Care Med. 2022;205(1):108–17. https://doi.org/10.1164/rccm.202105-1274OC. PMID: 34648724.CrossRefPubMed

24.

Kuna ST, et al. An official ATS/AASM/ACCP/ERS workshop report: Research priorities in ambulatory management of adults with obstructive sleep apnea. Proc Am Thorac Soc. 2011;8:1–16. https://doi.org/10.1513/pats.2009-042WS.CrossRefPubMed

25.

Chirinos JA, et al. CPAP, weight loss, or both for obstructive sleep apnea. New Engl J Med. 2014;370(24):2265–75. https://doi.org/10.1056/NEJMoa1306187.CrossRefPubMed

26.

Trzepizur W, et al. Health outcomes of continuous positive airway pressure versus mandibular advancement device for the treatment of severe obstructive sleep apnea: an individual participant data meta-analysis. Sleep. 2021;44(7):zsab015. https://doi.org/10.1093/sleep/zsab015.CrossRefPubMed

27.

• Walia HK, et al. Upper airway stimulation vs positive airway pressure impact on BP and sleepiness symptoms in OSA. Chest. 2020;157(1):173–83. https://doi.org/10.1016/j.chest.2019.06.020. This contemporary paper compares the impact of positive airway pressure versus hypoglossal nerve stimulation on sleepiness and blood pressure in patients with sleep apnea. Hypoglossal nerve stimulation is becoming increasingly popular among patients with sleep apnea and this manuscript is among the first to compare it to the current standard of care.CrossRefPubMed

28.

Gay P, Weaver T, Loube D, Iber C. Positive airway pressure task force; Standards of practice committee; American academy of sleep medicine. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep. 2006;29(3):381–401. https://doi.org/10.1093/sleep/29.3.381. PMID: 16553025.CrossRefPubMed

29.

Zeineddine S, Badr MS. Treatment-emergent central apnea: physiologic mechanisms informing clinical practice. Chest. 2021;159(6):2449–57. https://doi.org/10.1016/j.chest.2021.01.036. Epub 2021 Jan 23. PMID: 33497650; PMCID: PMC8411449.CrossRefPubMedPubMedCentral

30.

Zinchuk AV, Chu JH, Liang J, Celik Y, Op de Beeck S, Redeker NS, Wellman A, Yaggi HK, Peker Y, Sands SA. Physiological traits and adherence to sleep apnea therapy in individuals with coronary artery disease. Am J Respir Crit Care Med. 2021;204(6):703–12. https://doi.org/10.1164/rccm.202101-0055OC. PMID: 34156917; PMCID: PMC8521693.CrossRefPubMedPubMedCentral

Titel: Current Perspectives in Treatment of Obstructive Sleep Apnea: Positive Airway Pressure
verfasst von: Anirudh Nandan
Michael D. Faulx
Publikationsdatum: 03.05.2023
Verlag: Springer US
Erschienen in: Current Pulmonology Reports / Ausgabe 2/2023
Elektronische ISSN: 2199-2428
DOI: https://doi.org/10.1007/s13665-023-00308-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Bildnachweise

Die Leitlinien für Ärztinnen und Ärzte, Ärztin führt eine Nierenultraschalluntersuchung durch/© Graphicroyalty / stock.adobe.com (Symbolbild mit Fotomodell), Schwangere misst Blutzucker/© MMPhotography / Getty Images / iStock (Symbolbild mit Fotomodell), Duktales Pankreaskarzinom/© Dörffel, Y., Wermke, W. / all rights reserved Springer Medizin Verlag GmbH, Füße einer adipösen Frau auf einem Laufband/© Idanupong / stock.adobe.com (Symbolbild mit Fotomodell)

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2023

Correction: Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice

Improving Quality of Sleep in Healthy Adults

Diagnostic Approach and Management of Cardiac Sarcoidosis

Palliative Care and End-of-Life Decisions in Interstitial Lung Disease

Post COVID Interstitial Lung Abnormalities—Incidence and Management